Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice

被引:41
作者
Bianco, John [1 ]
Bastiancich, Chiara [1 ]
Joudiou, Nicolas [2 ]
Gallez, Bernard [2 ]
des Rieux, Anne [1 ,3 ]
Danhier, Fabienne [1 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Ave Mounier 73,Bl 73-12, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain La Neuve, Belgium
关键词
Glioblastoma; Tumour; Resection; Recurrence; Local drug delivery; RAT GLIOMA MODEL; ADJUVANT TEMOZOLOMIDE; TUMOR RESECTION; DRUG-DELIVERY; RADIOTHERAPY; IMPLANTATION; CONCOMITANT; HYDROGELS;
D O I
10.1016/j.jneumeth.2017.04.019
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In vitro and in vivo models of experimental glioma are useful tools to gain a better understanding of glioblastoma (GBM) and to investigate novel treatment strategies. However, the majority of preclinical models focus on treating solid intracranial tumours, despite surgical resection being the mainstay in the standard care of patients with GBM today. The lack of resection and recurrence models therefore has undermined efforts in finding a treatment for this disease. Here we present a novel orthotopic tumour resection and recurrence model that has potential for the investigation of local delivery strategies in the treatment of GBM. The model presented is simple to achieve through the use of a biopsy punch, is reproducible, does not require specific or expensive equipment, and results in a resection cavity suitable for local drug delivery systems, such as the implantation or injection of hydrogels. We show that tumour resection is well tolerated, does not induce deleterious neurological deficits, and significantly prolongs survival of mice bearing U-87 MG GBM tumours. In addition, the resulting cavity could accommodate adequate amounts of hydrogels for local delivery of chemotherapeutic agents to eliminate residual tumour cells that can induce tumour recurrence. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 17 条
[1]   Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection [J].
Akbar, Umar ;
Jones, Terreia ;
Winestone, Jon ;
Michael, Madison ;
Shukla, Atul ;
Sun, Yichun ;
Duntsch, Christopher .
JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (02) :203-212
[2]   Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review [J].
Ashby, Lynn S. ;
Smith, Kris A. ;
Stea, Baldassarre .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
[3]   Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma [J].
Bastiancich, C. ;
Danhier, P. ;
Preat, V. ;
Danhier, F. .
JOURNAL OF CONTROLLED RELEASE, 2016, 243 :29-42
[4]   Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model [J].
Bernardi, Andressa ;
Braganhol, Elizandra ;
Jaeger, Eliezer ;
Figueiro, Fabricio ;
Edelweiss, Maria Isabel ;
Pohlmann, Adriana R. ;
Guterres, Silvia S. ;
Battastini, Ana M. O. .
CANCER LETTERS, 2009, 281 (01) :53-63
[5]   First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience [J].
Bock, Hans Christoph ;
Puchner, Maximilian Josef Anton ;
Lohmann, Frauke ;
Schuetze, Michael ;
Koll, Simone ;
Ketter, Ralf ;
Buchalla, Ruediger ;
Rainov, Nikolai ;
Kantelhardt, Sven R. ;
Rohde, Veit ;
Giese, Alf .
NEUROSURGICAL REVIEW, 2010, 33 (04) :441-449
[6]   Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma [J].
Chaichana, Kaisorn L. ;
Jusue-Torres, Ignacio ;
Navarro-Ramirez, Rodrigo ;
Raza, Shaan M. ;
Pascual-Gallego, Maria ;
Ibrahim, Aly ;
Hernandez-Hermann, Marta ;
Gomez, Luis ;
Ye, Xiaobu ;
Weingart, Jon D. ;
Olivi, Alessandro ;
Blakeley, Jaishri ;
Gallia, Gary L. ;
Lim, Michael ;
Brem, Henry ;
Quinones-Hinojosa, Alfredo .
NEURO-ONCOLOGY, 2014, 16 (01) :113-122
[7]   Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation [J].
Danhier, Fabienne ;
Messaoudi, Khaled ;
Lemaire, Laurent ;
Benoit, Jean-Pierre ;
Lagarce, Frederic .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 481 (1-2) :154-161
[8]   Continuous local delivery of interferon-β stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model [J].
Denbo, Jason W. ;
Williams, Regan F. ;
Orr, W. Shannon ;
Sims, Thomas L. ;
Ng, Catherine Y. ;
Zhou, Junfang ;
Spence, Yunyu ;
Morton, Christopher L. ;
Nathwani, Amit C. ;
Duntsch, Christopher ;
Pfeffer, Lawrence M. ;
Davidoff, Andrew M. .
SURGERY, 2011, 150 (03) :497-504
[9]   Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence [J].
Fukui, Atsushi ;
Muragaki, Yoshihiro ;
Saito, Taiichi ;
Maruyama, Takashi ;
Nitta, Masayuki ;
Ikuta, Soko ;
Kawamata, Takakazu .
WORLD NEUROSURGERY, 2017, 98 :73-80
[10]   Hydrogels in drug delivery: Progress and challenges [J].
Hoare, Todd R. ;
Kohane, Daniel S. .
POLYMER, 2008, 49 (08) :1993-2007